Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

DEXCOM INC Director's Dealing 2025

Mar 10, 2025

30198_dirs_2025-03-10_3564577c-aa12-42a8-bc5e-f73e733aecc3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2025-03-06

Reporting Person: GALA RENEE D (Director)

More from DEXCOM INC

Regulatory Filings 2026
May 28
Regulatory Filings 2026
May 28
Regulatory Filings 2026
May 14
Interim / Quarterly Report 2026
Apr 30
Proxy Solicitation & Information Statement 2026
Apr 15
Major Shareholding Notification 2026
Mar 26
Regulatory Filings 2026
Mar 2
Director's Dealing 2026
Feb 26
Regulatory Filings 2026
Feb 26
Director's Dealing 2026
Feb 17
View all filings →